LONDON, UK: Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced that early results on the two-month-old direct to consumer program have exceeded the Board’s initial expectations. The company has introduced…
LONDON, UK: Belluscura plc (AIM: BELL), a leading innovator in medical devices specializing in lightweight and portable oxygen enrichment technology, has forged a significant Exclusive License, Marketing, and Distribution Agreement with global manufacturing partner InnoMax Medical Technology Ltd (“InnoMax”). InnoMax,…
LONDON, U.K: Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that, as anticipated, it has signed its first US distribution agreement for its X-PLO2R portable oxygen concentrator (POC) portfolio. This is the first stage in establishing…
LONDON: Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced its intention to list entire issued and to be issued ordinary share capital of the Company to the AIM market of the London…